BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15798414)

  • 21. URINARY EXCRETION OF CALCIUM AND CITRATE IN NORMAL INDIVIDUALS AND STONE FORMERS WITH VARIATION IN CALCIUM INTAKE.
    MCINTOSH HW; SERAGLIA M
    Can Med Assoc J; 1963 Dec; 89(24):1242-3. PubMed ID: 14084708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative Mineralogical Composition of Calculi and Urine Abnormalities for Calcium Oxalate Stone Formers: A Single-Center Results.
    Kustov AV; Strelnikov AI
    Urol J; 2018 May; 15(3):87-91. PubMed ID: 29277881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers.
    Massey LK; Sutton RA
    J Urol; 2004 Aug; 172(2):555-8. PubMed ID: 15247728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and dietary influences on urinary oxalate excretion.
    Holmes RP; Assimos DG; Goodman HO
    Urol Res; 1998; 26(3):195-200. PubMed ID: 9694602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potassium and sodium intake and excretion in calcium stone forming patients.
    Martini LA; Cuppari L; Cunha MA; Schor N; Heilberg IP
    J Ren Nutr; 1998 Jul; 8(3):127-31. PubMed ID: 9724501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for disordered acid-base handling in calcium stone-forming patients.
    Worcester EM; Bergsland KJ; Gillen DL; Coe FL
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F363-F374. PubMed ID: 31790303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence.
    Strohmaier WL; Seilnacht J; Schubert G
    Urol Int; 2012; 88(3):294-7. PubMed ID: 22398801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of renal function and metabolic abnormalities of cystine stone patients and calcium oxalate stone patients in China.
    Shen L; Sun X; Zhu H; Cong X; Ning B
    World J Urol; 2013 Oct; 31(5):1219-23. PubMed ID: 22622395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary style and acid load in an Italian population of calcium kidney stone formers.
    Vezzoli G; Dogliotti E; Terranegra A; Arcidiacono T; Macrina L; Tavecchia M; Pivari F; Mingione A; Brasacchio C; Nouvenne A; Meschi T; Cusi D; Spotti D; Montanari E; Soldati L
    Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):588-93. PubMed ID: 25921845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary citrate excretion in idiopathic nephrolithiasis.
    Ratan SK; Bhatnagar V; Mitra DK; Basu N; Malhotra LK
    Indian Pediatr; 2002 Sep; 39(9):819-25. PubMed ID: 12368525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multiregional Italian cohort of 24-hour urine metabolic evaluation in renal stone formers.
    Esperto F; Marangella M; Trinchieri A; Petrarulo M; Miano R
    Minerva Urol Nefrol; 2018 Feb; 70(1):87-94. PubMed ID: 28882031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Citrate inhibits growth of residual fragments in an in vitro model of calcium oxalate renal stones.
    Chow K; Dixon J; Gilpin S; Kavanagh JP; Rao PN
    Kidney Int; 2004 May; 65(5):1724-30. PubMed ID: 15086911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
    Negri AL; Spivacow FR; Del Valle EE; Forrester M; Rosende G; Pinduli I
    Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers.
    Trinchieri A; Lizzano R; Marchesotti F; Zanetti G
    Urol Res; 2006 Feb; 34(1):1-7. PubMed ID: 16425021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urine calcium/citrate ratio in children with hypercalciuric stones.
    Srivastava T; Winston MJ; Auron A; Alon US
    Pediatr Res; 2009 Jul; 66(1):85-90. PubMed ID: 19287339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potassium-sodium citrate prevents the development of renal microcalculi into symptomatic stones in calcium stone-forming patients.
    Unno R; Taguchi K; Okada A; Ando R; Hamamoto S; Kubota Y; Zuo L; Tozawa K; Kohri K; Yasui T
    Int J Urol; 2017 Jan; 24(1):75-81. PubMed ID: 27747937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.